Ernexa Therapeutics Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$7.03

+0.06 (+0.86%)

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 50%

Sell 3 50%

Price Target

Analyst Price Target +337.7% upside

Low Target $21.48

Average Target $30.77

High Target $35.71

Current Price $7.03

Current
$7.03

Target
$30.77

$21.48 $30.77 avg $35.71

Scenario Analysis

Bear Case

$21.48

205.5%

Low target

Base Case

$30.77

+337.7%

Avg target

Bull Case

$35.71

+408.0%

High target

Risk/Reward

2.0x

Balanced

Price in Context

52-Week High

$71.50

-90.2% from high

52-Week Low

$3.18

+120.9% from low

Target vs 52W High

$30.77

-57.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+1.3%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.1%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-12.3%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.1%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-40.8%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.5%